Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FEM (FEM Self-care) is a Dutch health-technology company focused on empowering women through personalized hormone health management. The company offers a saliva-based home testing kit that allows users to track key hormonal biomarkers, such as progesterone, throughout their menstrual cycle. This diagnostic data is paired with a mobile application that provides data-driven insights and personalized lifestyle recommendations to help manage symptoms of PMS, optimize fertility, and improve overall well-being. By providing accessible, lab-quality testing and actionable health data, FEM aims to address the historical lack of research and personalized care in women's health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FEM self-care.